AnGes Inc
TSE:4563

Watchlist Manager
AnGes Inc Logo
AnGes Inc
TSE:4563
Watchlist
Price: 59 JPY Market Closed
Market Cap: ¥22.9B

Operating Margin

-3 141.3%
Current
Improving
by 5 375.8%
vs 3-y average of -8 517.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3 141.3%
=
Operating Income
¥-25.7B
/
Revenue
¥818.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3 141.3%
=
Operating Income
¥-25.7B
/
Revenue
¥818.1m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
AnGes Inc
TSE:4563
22.8B JPY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-3 141.3%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

AnGes Inc
Glance View

Market Cap
22.9B JPY
Industry
Biotechnology

AnGes, Inc. engages in the research and development of gene-based medical products. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 131 full-time employees. The company went IPO on 2002-09-25. The firm is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.

AnGes Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-3 141.3%
=
Operating Income
¥-25.7B
/
Revenue
¥818.1m
What is AnGes Inc's current Operating Margin?

The current Operating Margin for AnGes Inc is -3 141.3%, which is above its 3-year median of -8 517.1%.

How has Operating Margin changed over time?

Over the last 3 years, AnGes Inc’s Operating Margin has increased from -24 299.9% to -3 141.3%. During this period, it reached a low of -24 320.8% on Dec 31, 2022 and a high of -1 415.3% on Dec 31, 2024.

Back to Top